Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top Gainers - Equitymaster
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top GainersEquitymaster
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top Gainers - Equitymaster
Sensex Today Trades Flat | Nifty Above 24,100 | Sun Pharma & Trent Top GainersEquitymaster
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
Beyond the hype: 5 under-the-radar stocks common across India's 3 largest smallcap portfolios
India's top three smallcap mutual funds, managing over Rs 1.5 lakh crore, show strong consensus by holding five under-the-radar stocks across their portfolios. These include Kalpataru Projects International, KIMS, City Union Bank, PVR Inox, and Carborundum Universal, collectively representing 5.34% of their combined assets.
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for Biocon
Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalizing on growing demand as major pharmaceutical companies shift focus to newer weight-loss drugs. Currently the third-largest global insulin provider, Biocon is significantly expanding production. This strategic move addresses a critical gap in the market, particularly in emerging economies.

Nifty 50 target cut by Citi to 26,000 - Key risk factors, top picks explained
Citi has highlighted Financials, Telecom, Healthcare, Defence and Utilities as their key "overweights", while IT Services, Staples, Metals are their top "underweights." It has also added Hitachi Energy into its list of top picks having initiated coverage on the stock recently.
Further consolidation ahead for Nifty? Here's today's outlook and top picks
Ajit Mishra of Religare Broking has recommended buying the shares of Fortis Healthcare, RBL Bank, and Eternal today
Ambani-backed robot startup seeks $100 million to take on China
Reliance-backed robotics startup Addverb Technologies is looking to raise over $100 million to fund expansion into humanoid robots, AI and advanced automation. The company, which generates half its revenue overseas, targets a spot among the world's top 10 robotics firms within five years.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.